A review of diseases related to the intake of gluten;Revisión de las patologías relacionadas con la ingesta de gluten

Nutricion Hospitalaria

Volumn 31, Issue 6, 2015, Pages 2359-2371

  Vaquero, Luis ^a   Alvarez Cuenllas, Begoña ^a   Rodríguez Martín, Laura ^a   Aparicio, Marta ^a   Jorquera, Francisco ^a,b   Olcoz, José Luis ^a,b   Vivas, Santiago ^a  

^a Gerencia Regional de Salud de Castilla y León   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Celiac disease; Gluten; Non celiac gluten sensitivity; Wheat allergy

Indexed keywords

HORDEUM; SECALE CEREALE; TRITICUM AESTIVUM;

GLUTEN;

CELIAC DISEASE; DIET THERAPY; GLUTEN FREE DIET; HUMAN; MALABSORPTION; PATHOPHYSIOLOGY; WHEAT HYPERSENSITIVITY;

CELIAC DISEASE; DIET, GLUTEN-FREE; GLUTENS; HUMANS; MALABSORPTION SYNDROMES; WHEAT HYPERSENSITIVITY;

EID: 84930170200     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2015.31.6.8984     Document Type: Article

References (112)

1. Pompa M, Giuliani MM, Palermo C, Agriesti F, Centonze D, Flagella Z. Comparative Analysis of Gluten Proteins in Three Durum Wheat Cultivars by a Proteomic Approach. J Agric Food Chem 2013.
2. He J, Penson S, Powers SJ, Hawes C, Shewry PR, Tosi P. Spatial patterns of gluten protein and polymer distribution in wheat grain. J Agric Food Chem 2013;61:6207-15.
3. Bernardo D, Garrote JA, Nadal I, Leon AJ, Calvo C, Fernandez-Salazar L, et al. Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa. Gut 2009;58:886-7.
4. Weijers HA, va de KJ. Some biochemical investigations into the cause of wheat sensitivity in celiac disease. Gastroenterology 1960;38:587-91.
5. van RJ, Haex AJ, Seeder WA, de J. Clinical and biochemical analysis of gluten toxicity. I. Experientia 1960;16:209.
6. Barada K, Abu Daya H, Rostami K, Catassi C. Celiac disease in the developing world. Gastrointestinal endoscopy clinics of North America 2012;22:773-96.
7. Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P, Drijfhout JW, Jonker H, van Soest L, et al. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 2005;129:797-806.
8. Nakamura A, Tanabe S, Watanabe J, Makino T. Primary screening of relatively less allergenic wheat varieties. Journal of nutritional science and vitaminology 2005;51:204-6.
9. Kearney J. Food consumption trends and drivers. Philosophical transactions of the Royal Society of London Series B, Biological sciences 2010;365:2793-807.
10. Leonard MM, Vasagar B. US perspective on gluten-related diseases. Clinical and experimental gastroenterology 2014;7:25-37.
11. Fasano A, Catassi C. Clinical practice. Celiac disease. The New England journal of medicine 2012;367:2419-26.
12. Green PH, Cellier C. Celiac disease. The New England journal of medicine 2007;357:1731-43.
13. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009;373:1480-93.
14. Tavakkoli A, DiGiacomo D, Green PH, Lebwohl B. Vitamin D status and concomitant autoimmunity in celiac disease. J Clin Gastroenterol 2013;47:515-9.
15. Ludvigsson JF, Rubio-Tapia A, van Dyke CT, Melton LJ, 3rd, Zinsmeister AR, Lahr BD, et al. Increasing incidence of celiac disease in a North American population. The American journal of gastroenterology 2013;108:818-24.
16. Rodrigo L, Garrote JA, Vivas S. [Celiac disease]. Medicina clinica 2008;131:264-70.
17. Kratzer W, Kibele M, Akinli A, Porzner M, Boehm BO, Koenig W, et al. Prevalence of celiac disease in Germany: a prospective follow-up study. World journal of gastroenterology: WJG 2013;19:2612-20.
18. Vivas S, Ruiz de Morales JM, Fernandez M, Hernando M, Herrero B, Casqueiro J, et al. Age-related clinical, serological, and histopathological features of celiac disease. The American journal of gastroenterology 2008;103:2360-5; quiz 6.
19. Vivas S, Ruiz de Morales JG, Riestra S, Arias L, Fuentes D, Alvarez N, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World journal of gastroenterology: WJG 2009;15:4775-80.
20. Vivas S, Ruiz de Morales JM, Martinez J, Gonzalez MC, Martin S, Martin J, et al. Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients. European journal of gastroenterology & hepatology 2003;15:479-83.
21. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World journal of gastroenterology: WJG 2012;18:6036-59.
22. Vaquero L, Caminero A, Nunez A, Hernando M, Iglesias C, Casqueiro J, et al. Coeliac disease screening in first-degree relatives on the basis of biopsy and genetic risk. European journal of gastroenterology & hepatology 2014;26:263-7.
23. Ahn R, Ding YC, Murray J, Fasano A, Green PH, Neuhausen SL, et al. Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci. PloS one 2012;7:e36926.
24. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009;137:1912-33.
25. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30-7.
26. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Rispo A, et al. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology 2005;129:1400-13.
27. Beckett CG, Dell’Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ. Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies. Eur J Gastroenterol Hepatol 1999;11:529-35.
28. Murray IA, Daniels I, Coupland K, Smith JA, Long RG. Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease. Am J Physiol Gastrointest Liver Physiol 2002;283:G319-26.
29. Daniels I, Cavill D, Murray IA, Long RG. Elevated expression of iNOS mRNA and protein in coeliac disease. Clin Chim Acta 2005;356:134-42.
30. De Stefano D, Maiuri MC, Iovine B, Ialenti A, Bevilacqua MA, Carnuccio R. The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. Journal of molecular medicine 2006;84:65-74.
31. Martin-Pagola A, Perez-Nanclares G, Ortiz L, Vitoria JC, Hualde I, Zaballa R, et al. MICA response to gliadin in intestinal mucosa from celiac patients. Immunogenetics 2004;56:549-54.
32. Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003;52:218-23.
33. Sander GR, Cummins AG, Henshall T, Powell BC. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett 2005;579:4851-5.
34. Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM, et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006;55:469-77.
35. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004;21:357-66.
36. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-77.
37. Raki M, Tollefsen S, Molberg O, Lundin KE, Sollid LM, Jahnsen FL. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 2006;131:428-38.
38. Yoshimura S, Bondeson J, Brennan FM, Foxwell BM, Feldmann M. Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol 2001;31:1883-93.
39. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002;16:257-70.
40. Ohteki T, Tada H, Ishida K, Sato T, Maki C, Yamada T, et al. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J Exp Med 2006;203:2329-38.
41. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nature reviews Immunology 2003;3:331-41.
42. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-42.
43. Arentz-Hansen H, McAdam SN, Molberg O, Fleckenstein B, Lundin KE, Jorgensen TJ, et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002;123:803-9.
44. Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998;115:551-63.
45. Leon AJ, Garrote JA, Blanco-Quiros A, Calvo C, Fernandez-Salazar L, Del Villar A, et al. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. Clin Exp Immunol 2006;146:479-85.
46. MacDonald TT, Bajaj-Elliott M, Pender SL. T cells orchestrate intestinal mucosal shape and integrity. Immunology today 1999;20:505-10.
47. Jabri B, Sollid LM. Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol 2006;3:516-25.
48. Ivarsson A, Myleus A, Norstrom F, van der Pals M, Rosen A, Hogberg L, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics 2013;131:e687-94.
49. Vriezinga SL, Mearin ML. [Gluten tolerance as a result of earlier exposure?]. Nederlands tijdschrift voor geneeskunde 2013;157:A6349.
50. Ludvigsson JF, Fasano A. Timing of introduction of gluten and celiac disease risk. Ann Nutr Metab 2012;60 Suppl 2:22-9.
51. Pozo-Rubio T, de Palma G, Mujico JR, Olivares M, Marcos A, Acuna MD, et al. Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study. Nutr Hosp 2013;28:464-73.
52. Laparra JM, Olivares M, Sanz Y. Oral administration of Bifidobacterium longum CECT 7347 ameliorates gliadin-induced alterations in liver iron mobilisation. Br J Nutr 2013: 1-9.
53. Pozo-Rubio T, Olivares M, Nova E, De Palma G, Mujico JR, Ferrer MD, et al. Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol 2012;2012: 654143.
54. Caminero A, Nistal E, Arias L, Vivas S, Comino I, Real A, et al. A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity. European journal of nutrition 2012;51:293-9.
55. Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, Partanen J, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflammatory bowel diseases 2013;19:934-41.
56. Tjellstrom B, Stenhammar L, Hogberg L, Falth-Magnusson K, Magnusson KE, Midtvedt T, et al. Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol 2005;100:2784-8.
57. Sollid LM, Gray GM. A role for bacteria in celiac disease? Am J Gastroenterol 2004;99:905-6.
58. Caminero A, Herran AR, Nistal E, Perez-Andres J, Vaquero L, Vivas S, et al. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS microbiology ecology 2014;88:309-19.
59. Nistal E, Caminero A, Herran AR, Arias L, Vivas S, de Morales JM, et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflammatory bowel diseases 2012;18:649-56.
60. Nistal E, Caminero A, Vivas S, Ruiz de Morales JM, Saenz de Miera LE, Rodriguez-Aparicio LB, et al. Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie 2012;94: 1724-9.
61. Murray JA, Rubio-Tapia A. Diarrhoea due to small bowel diseases. Best Pract Res Clin Gastroenterol 2012;26:581-600.
62. Guarino A, Lo Vecchio A, Berni Canani R. Chronic diarrhoea in children. Best Pract Res Clin Gastroenterol 2012;26: 649-61.
63. Sharma M, Singh P, Agnihotri A, Das P, Mishra A, Verma AK, et al. Celiac disease: A disease with varied manifestations in adults and adolescents. J Dig Dis 2013.
64. Carroccio A, Iannitto E, Cavataio F, Montalto G, Tumminello M, Campagna P, et al. Sideropenic anemia and celiac disease: one study, two points of view. Digestive diseases and sciences 1998;43:673-8.
65. Hijaz NM, Bracken JM, Chandratre SR. Celiac crisis presenting with status epilepticus and encephalopathy. Eur J Pediatr 2013.
66. Rodrigo Saez L. Celiac disease in the adult. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva 2006;98:397-407.
67. Pulido O, Zarkadas M, Dubois S, Macisaac K, Cantin I, La Vieille S, et al. Clinical features and symptom recovery on a gluten-free diet in Canadian adults with celiac disease. Can J Gastroenterol 2013;27:449-53.
68. Tanpowpong P, Broder-Fingert S, Katz AJ, Camargo CA, Jr. Age-related patterns in clinical presentations and gluten-related issues among children and adolescents with celiac disease. Clin Transl Gastroenterol 2012;3:e9.
69. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. European journal of gastroenterology & hepatology 1999;11:1185-94.
70. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52.
71. Gasbarrini G, Mangiola F. Wheat-related disorders: A broad spectrum of ‘evolving’ diseases. United European gastroenterology journal 2014;2:254-62.
72. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. The American journal of gastroenterology 2011;106:508-14; quiz 15.
73. Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC medicine 2012;10:13.
74. Volta U, Tovoli F, Cicola R, Parisi C, Fabbri A, Piscaglia M, et al. Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol 2012;46:680-5.
75. Sapone A, Lammers KM, Mazzarella G, Mikhailenko I, Carteni M, Casolaro V, et al. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol 2010;152:75-80.
76. Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, De Rosa M, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC medicine 2011;9:23.
77. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of gastroenterology and hepatology 2010;25:252-8.
78. Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. Journal of gastroenterology and hepatology 2010;25:1366-73.
79. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. The American journal of gastroenterology 2005;100:2560-8.
80. Tornblom H, Abrahamsson H, Barbara G, Hellstrom PM, Lindberg G, Nyhlin H, et al. Inflammation as a cause of functional bowel disorders. Scand J Gastroenterol 2005;40: 1140-8.
81. Pan H, Gershon MD. Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci 2000;20:3295-309.
82. Brehmer A, Croner R, Dimmler A, Papadopoulos T, Schrodl F, Neuhuber W. Immunohistochemical characterization of putative primary afferent (sensory) myenteric neurons in human small intestine. Auton Neurosci 2004;112:49-59.
83. Verdu EF, Huang X, Natividad J, Lu J, Blennerhassett PA, David CS, et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol 2008;294:G217-25.
84. Carroccio A, Brusca I, Mansueto P, Pirrone G, Barrale M, Di Prima L, et al. A cytologic assay for diagnosis of food hypersensitivity in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2010;8:254-60.
85. Giorgetti GM, Tursi A, Iani C, Arciprete F, Brandimarte G, Capria A, et al. Assessment of autonomic function in untreated adult coeliac disease. World journal of gastroenterology: WJG 2004;10:2715-8.
86. Gibbons CH, Freeman R. Autonomic neuropathy and coeliac disease. J Neurol Neurosurg Psychiatry 2005;76:579-81.
87. Pan H, Galligan JJ. 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol 1994;266:G230-8.
88. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126:1657-64.
89. Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 2005;34:235-45, vi-vii.
90. Coleman NS, Foley S, Dunlop SP, Wheatcroft J, Blackshaw E, Perkins AC, et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol 2006;4:874-81.
91. Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: beyond the gut. Trends Immunol 2004;25:578-82.
92. Giovannini C, Sanchez M, Straface E, Scazzocchio B, Silano M, De Vincenzi M. Induction of apoptosis in caco-2 cells by wheat gliadin peptides. Toxicology 2000;145:63-71.
93. van Elburg RM, Uil JJ, Mulder CJ, Heymans HS. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut 1993;34:354-7.
94. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008;6:765-71.
95. Volta U, Caio G, Tovoli F, De Giorgio R. Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness. Cellular & molecular immunology 2013;10:383-92.
96. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the “no man’s land” of gluten sensitivity. The American journal of gastroenterology 2009;104:1587-94.
97. Volta U, Corazza GR, Frisoni M, Valentini RA, Molinaro N, Bianchi FB, et al. IgA antigliadin antibodies and persistence of jejunal lesions in adult coeliac disease. Digestion 1990;47:111-4.
98. Bizzaro N, Tozzoli R, Villalta D, Fabris M, Tonutti E. Cutting-edge issues in celiac disease and in gluten intolerance. Clinical reviews in allergy & immunology 2012;42:279-87.
99. Calleja S, Vivas S, Santiuste M, Arias L, Hernando M, Nistal E, et al. Dynamics of non-conventional intraepithelial lymphocytes-NK, NKT, and gammadelta T-in celiac disease: relationship with age, diet, and histopathology. Digestive diseases and sciences 2011;56:2042-9.
100. Volta U, De Giorgio R. New understanding of gluten sensitivity. Nat Rev Gastroenterol Hepatol 2012;9:295-9.
101. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. The Journal of allergy and clinical immunology 2004;113:832-6.
102. Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. The Journal of allergy and clinical immunology 1999;103:717-28.
103. Zuidmeer L, Goldhahn K, Rona RJ, Gislason D, Madsen C, Summers C, et al. The prevalence of plant food allergies: a systematic review. The Journal of allergy and clinical immunology 2008;121:1210-8 e4.
104. Novembre E, de Martino M, Vierucci A. Foods and respiratory allergy. The Journal of allergy and clinical immunology 1988;81:1059-65.
105. Niggemann B, Reibel S, Roehr CC, Felger D, Ziegert M, Sommerfeld C, et al. Predictors of positive food challenge outcome in non-IgE-mediated reactions to food in children with atopic dermatitis. The Journal of allergy and clinical immunology 2001;108:1053-8.
106. Brisman J. Baker’s asthma. Occupational and environmental medicine 2002;59:498-502; quiz, 426.
107. Keet CA, Matsui EC, Dhillon G, Lenehan P, Paterakis M, Wood RA. The natural history of wheat allergy. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 2009;102:410-5.
108. Inomata N. Wheat allergy. Current opinion in allergy and clinical immunology 2009;9:238-43.
109. Scibilia J, Pastorello EA, Zisa G, Ottolenghi A, Bindslev-Jensen C, Pravettoni V, et al. Wheat allergy: a double-blind, placebo-controlled study in adults. The Journal of allergy and clinical immunology 2006;117:433-9.
110. Crespo JF, Rodriguez J. Food allergy in adulthood. Allergy 2003;58:98-113.
111. Majamaa H, Moisio P, Holm K, Turjanmaa K. Wheat allergy: diagnostic accuracy of skin prick and patch tests and specific IgE. Allergy 1999;54:851-6.
112. Simpson S, Thompson T. Nutrition assessment in celiac disease. Gastrointestinal endoscopy clinics of North America 2012;22:797-809.